[HTML][HTML] In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19
BR Bharath, H Damle, S Ganju, L Damle - F1000Research, 2020 - ncbi.nlm.nih.gov
Background: Human coronavirus (SARS-CoV-2) is causing a pandemic with significant
morbidity and mortality. As no effective novel drugs are available currently, drug repurposing is …
morbidity and mortality. As no effective novel drugs are available currently, drug repurposing is …
[HTML][HTML] In silico, in vitro screening of plant extracts for anti-SARS-CoV-2 activity and evaluation of their acute and sub-acute toxicity
D Latha, D Hrishikesh, G Shiban, C Chandrashekar… - Phytomedicine Plus, 2022 - Elsevier
… Latha Damle is the founder of Atrimed Biotech LLP and holds equity in Atrimed Pharmaceuticals.
Shiban Ganju and Hrishikesh Damle hold equity shares in Atrimed Pharmaceuticals. …
Shiban Ganju and Hrishikesh Damle hold equity shares in Atrimed Pharmaceuticals. …
[HTML][HTML] Plant formulation ATRICOV 452 in improving the level of COVID-19 specific inflammatory markers in patients
L Damle, H Damle, BR Bharath - Contemporary Clinical Trials …, 2022 - Elsevier
… competing interests: Latha Damle is the founder of Atrimed Biotech LLP and holds equity in
Atrimed Pharmaceuticals. Hrishikesh Damle hold equity shares in Atrimed Pharmaceuticals. …
Atrimed Pharmaceuticals. Hrishikesh Damle hold equity shares in Atrimed Pharmaceuticals. …
Steroid sparing effect of a herbal preparation in steroid-dependent nephrotic syndrome
A Iyengar, H Damle, C Kulkarni, L Damle… - Pediatric Nephrology, 2006 - Springer
Investigations on plants are revealing the potential therapeutic benefits of medicinal herbs
in treating immunological disorders. Nephrotic syndrome has emerged as an immunological …
in treating immunological disorders. Nephrotic syndrome has emerged as an immunological …
In silico, In vitro Screening of Plant Extracts for Anti-SARS-CoV-2 Activity and Evaluation of Their Acute and Sub-Acute Toxicity
L Damle, H Damle, S Ganju, C Chandrashekar… - bioRxiv, 2021 - biorxiv.org
… Competing interests: Latha Damle is the founder of Atrimed Biotech LLP and holds equity
in Atrimed Pharmaceuticals. Shiban Ganju and Hrishikesh Damle hold equity shares in …
in Atrimed Pharmaceuticals. Shiban Ganju and Hrishikesh Damle hold equity shares in …
In silico, In vitro Screening of Plant Extracts for Anti-SARS-CoV-2 Activity and Evaluation of Their Acute and Sub-Acute Toxicity (preprint)
L Damle, H Damle, S Ganju, C Chandrashekar… - 2021 - pesquisa.bvsalud.org
BackgroundIn the absence of a specific drug for COVID 19, treatment with plant extracts could
be an option worthy of further investigation. PurposeTo screen the phytochemicals for Anti-…
be an option worthy of further investigation. PurposeTo screen the phytochemicals for Anti-…
Plant Formulation ATRICOV 452 in Improving the Level of COVID-19 Specific Inflammatory Markers in Patients (preprint)
L Damle Sr, H Damle Sr, BR Bharath Sr - 2021 - pesquisa.bvsalud.org
Due to the huge demand for health care facilities, there is a need for safe therapeutic intervention
which can reduce the need for extensive health care support. In that regard, the current …
which can reduce the need for extensive health care support. In that regard, the current …
Steroid sparing effect of a herbal preparation in steroid-dependent nephrotic syndrome.
…, CK Chanda Kulkarni, LD Latha Damle… - 2006 - cabidigitallibrary.org
Investigations on plants are revealing the potential therapeutic benefits of medicinal herbs
in treating immunological disorders. Nephrotic syndrome has emerged as an immunological …
in treating immunological disorders. Nephrotic syndrome has emerged as an immunological …
Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies
…, AG Popplewell, S Stephens, P Frost, NK Damle - Blood, 2004 - ashpublications.org
Antibody-targeted chemotherapy with gemtuzumab ozogamicin (CMA-676, a CD33-targeted
immunoconjugate of N-acetyl-γ-calicheamicin dimethyl hydrazide [CalichDMH], a potent …
immunoconjugate of N-acetyl-γ-calicheamicin dimethyl hydrazide [CalichDMH], a potent …
Determination of pharmacokinetic values of calicheamicin-antibody conjugates in mice by plasmon resonance analysis of small (5 μl) blood samples
…, PR Hamann, J Moran, I Chaudhary, NK Damle - Cancer chemotherapy …, 2008 - Springer
Purpose The present study aims to establish a method that provides fast, precise and
reproducible pharmacokinetic (PK) parameters of antibody-calicheamicin conjugates. The method …
reproducible pharmacokinetic (PK) parameters of antibody-calicheamicin conjugates. The method …
